Adma Biologics (ADMA) Misses Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts ADMA Hot Sheet
Join SI Premium – FREE
Adma Biologics (NASDAQ: ADMA) reported Q2 EPS of ($0.44), $0.08 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $1.3 million, versus $1.5 million reported last year.
For earnings history and earnings-related data on Adma Biologics (ADMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Webull Corp (BULL) Tops Q2 EPS by 1c
- FOMC minutes from July 28-29th meeting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
